SALL4, a zinc-finger transcriptional factor for embryonic stem cell self-renewal and pluripotency, has been suggested to be involved in tumorigenesis. The role of SALL4 in human gastric cancer, however, remains largely unknown. In this study, we demonstrated that SALL4 was aberrantly expressed at both mRNA and protein levels in human gastric cancer tissues, and SALL4 level was highly correlated with lymph node metastasis. Enforced expression of SALL4 enhanced the proliferation and migration of human gastric cancer cells, whereas knockdown of SALL4 by siRNA led to the opposite effects. In addition, SALL4 overexpression promoted the growth and metastasis of gastric xenograft tumor in vivo. SALL4 overexpression induced epithelial-mesenchymal transition (EMT) in gastric cancer cells, with increased expression of Twist1, N-cadherin and decreased expression of E-cadherin. Moreover, SALL4 promoted the acquirement of stemness in gastric cancer cells through the induction of Bmi-1 and Lin28B. Taken together, our findings indicate that SALL4 has oncogenic roles in gastric cancer through the modulation of EMT and cell stemness, suggesting SALL4 as a novel target for human gastric cancer diagnosis and therapy.
INTRODUCTION
Gastric cancer is the fourth most common cancer and the second leading cause of cancer-related death worldwide. [1] [2] [3] Gastric cancer remains difficult to cure primarily because most of patients present with advanced disease. Even patients who present in the most favorable condition and who undergo surgical resection often die of recurrent disease. Therefore, there is an urgent need to seek for novel biomarkers for the early diagnosis of gastric cancer and new targets for gastric cancer therapy.
SALL4 is a member of the SALL gene family and acts as a zincfinger transcription factor. The previous studies have demonstrated that SALL4 has an essential role in maintaining the selfrenewal and pluripotency of embryonic stem cells. [4] [5] [6] [7] [8] SALL4 maintains the stemness of embryonic stem cells by forming a regulatory circuit with Oct4, Nanog and Sox2. 5, 6, [8] [9] [10] [11] SALL4 has been shown to participate in normal hematopoiesis, and dysfunctional SALL4 signaling has been linked to leukemogenesis. SALL4 is found to be constitutively expressed in acute myeloid leukemia, in which it acts as an effector of the Wnt/b-catenin signaling pathway. 12 In addition, SALL4 is suggested to regulate the self-renewal of leukemic stem cells. 13 Furthermore, the aberrant expression of SALL4 has also been found in solid tumors. SALL4 has been indicated as a specific marker for detecting metastatic yolk sac tumors in metastatic germ cell tumors.
14 SALL4 mRNA is elevated in 86.1% (31/36) of early stage breast cancer specimens. 15 SALL4 overexpression has also been observed in human liver cancer. 16 Although accumulating evidence indicates that SALL4 is involved in tumorigenesis, little is known about the role of SALL4 in gastric cancer. In the previous studies, SALL4 has been suggested as a sensitive marker for alpha-fetoprotein (AFP)-producing gastric cancer and is helpful to distinguish hepatoid gastric cancer from hepatocellular cancer. 17 Distinct SALL4 expression pattern has been observed in hepatoid (89%), glandular (57%) and clear cell (39%) AFP-producing gastric cancers. In the current study, we aimed to investigate the role of SALL4 in gastric cancer and explore the underlying mechanism of action. We demonstrated that SALL4 expression was elevated at both mRNA and protein levels in gastric cancer tissues, and SALL4 overexpression promoted the growth and metastasis of gastric cancer cells in vitro and in vivo through the regulation of epithelial-mesenchymal transition (EMT) and cell stemness.
RESULTS
SALL4 level is upregulated in gastric cancer and associated with lymph node metastasis To determine the expression of SALL4 in gastric cancer, we performed reverse transcriptase-PCR (RT-PCR) and real-time RT-PCR on 72 paired non-cancerous and gastric cancer tissues. The results showed that SALL4 mRNA levels in gastric cancer tissues were significantly higher than that in the matched non-cancerous tissues (Po0.0001; Figure 1a ). SALL4 mRNA level had a more than twofold increase in 79.2% (57/72) of gastric cancer tissues (Figure 1b) . The correlation between SALL4 expression and clinicopathological characteristics was further analyzed. Gastric cancer tissues with more than twofold of SALL4 mRNA (relative to adjacent normal control) was defined as high group, while those with less than twofold increase or a slight decrease of SALL4 mRNA was interpreted as low group. As shown in Table 1 , 75.4% (43/57) of patients with high levels of SALL4 and 40% (6/15) of patients with low levels of SALL4 showed lymph node metastasis. SALL4 level was highly associated with the presence of lymph node metastasis (P ¼ 0.0134). However, no significant differences were observed between SALL4 level and age, gender, tumor size, histological grade, liver metastasis or clinical stage. Overall survival analysis showed that patients in the high SALL4 group had a poorer prognosis than those in the low SALL4 group (Po0.05; logrank test; Supplementary Figure S1 ).
We next determined the expression of SALL4 protein by western blotting and found that SALL4 protein levels were also increased in gastric cancer tissues (Figure 1c) . The results of immunohistochemical staining showed that SALL4 protein was predominantly expressed in the nucleus with a diffuse distribution in the cytoplasm in gastric cancer cells (Figure 1d ). Low or undetectable expression of SALL4 was observed in non-neoplastic gastric tissues, including intestinal metaplasia lesions (Figure 1e ). In general, poorly differentiated gastric adenocarcinoma had a stronger staining of SALL4 than that of well-differentiated adenocarcinoma, and patients with lymph node metastasis showed more intense staining for SALL4 than those without lymph node metastasis (Supplementary Tables S1 and S2 ). However, real-time RT-PCR results did not reveal the association between SALL4 expression and differentiation state, which was probably due to the samples used for real-time RT-PCR that might contain other types of cells.
SALL4 level is associated with the migratory ability of gastric cancer cells To confirm the correlation between SALL4 level and cancer metastasis, we analyzed the expression of SALL4 in four gastric cancer cell lines (MGC80-3, AGS, SGC-7901 and HGC-27) by using real-time RT-PCR and immunofluorescent staining. We found that SALL4 levels were notably higher in MGC80-3, AGS, and SGC-7901 cells than that in HGC-27 cells (Figures 2a and b) . We then performed transwell migration assay to compare the migratory ability of these gastric cancer cell lines. The results showed that HGC-27 cells, which had the lowest level of SALL4, displayed the weakest migratory potential (Figure 2c ). In brief, these findings suggest that SALL4 may be a determinant of the migratory ability in gastric cancer cells. SALL4 overexpression enhances the proliferation and migration of HGC-27 cells To further investigate the function of SALL4 in gastric cancer, we generated SALL4-overexpressing HGC-27 cells. The stable expression of SALL4 in HGC-27 cells was confirmed by real-time RT-PCR and immunofluorescence staining (Figures 3a and b) . The SALL4-overexpressing HGC-27 cells grew faster ( Figure 3c ) and formed larger and dispersed clones than the mock cells ( Figure 3d ). In addition, the SALL4-overexpressing HGC-27 cells migrated more efficiently than the mock cells (Figure 3e ). To better understand the effects of SALL4 overexpression on HGC-27 cell growth, we analyzed the expression of various proteins by using western blotting. The results showed that SALL4 overexpression increased the levels of phosphorylated ERK1/2, total ERK1/2, JNK and Bcl-2 but decreased the expression of Bax (Figure 3f ). Figure S2d) . Although the reliance on a single siRNA does not formally exclude an off-target effect, it is notable that the specific SALL4 knockdown phenotype is opposite to that from SALL4 overexpression. Thus, taken together, our results suggest that SALL4 knockdown inhibits gastric cancer cell growth and migration in vitro.
SALL4 induces EMT and pluripotency in gastric cancer cells
The role of SALL4 in cell migration led us to examine if SALL4 had any effect on the development of EMT in gastric cancer cells. The results of western blotting showed that SALL4 overexpression reduced the expression of epithelial cell marker (E-cadherin) and induced the expression of mesenchymal cell markers (N-cadherin, Vimentin and Twist1) in HGC-27 cells (Figure 5a ). Immunofluorescent staining also confirmed the increase of N-cadherin level in SALL4-overexpressing HGC-27 cells (Figure 5b ). In contrary, knockdown of SALL4 had an opposite effect on the expression of these proteins in SGC-7901 cells (Supplementary Figure S3) . In summary, these data suggest that SALL4 regulate the process of EMT, resulting in the enhanced migratory ability of gastric cancer cells in vitro.
Increasing evidences have suggested a close link between EMT and cell stemness. [18] [19] [20] To elucidate whether SALL4 overexpression could induce stem cell properties in gastric cancer cells, we first examined the expression of stem cell markers in SALL4-ovexpressing cells. As shown in Figure 5c , enforced expression of SALL4 increased Sox2, Bmi1, CD133 and Lin28B protein levels in HGC-27 cells. We next determined the induced differentiation potential of HGC-27 cells that stably expressed SALL4. The results showed that SALL4-overexpressing HGC-27 cells could be efficiently induced to differentiate into osteoblastes and adipocytes in the appropriate condition medium, whereas mock cells showed no obvious differentiation (Figure 5d ), 
SALL4 overexpression promotes tumorigenesis and metastasis in vivo
To investigate whether SALL4 overexpression could promote gastric cancer growth and metastasis in vivo, we used the SALL4-overexpressing HGC-27 cells to establish xenograft tumor models in nude mice. Representative images of tumor-bearing mice were shown in Figure 6a . SALL4-overexpressing HGC-27 cells formed subcutaneous tumors earlier than mock cells. In the SALL4 group, tumor nodule started to form at 6 days after injection, and the tumor incidence reached 100% at 14 days after injection. However, tumor incidence in vector group was only 66.7% at 32 days after implantation (Figure 6b ). The tumors in SALL4 group grew faster, and the tumor weight was higher than that in the vector group (Figures 6c and d) . The mean tumor volume in the SALL4 group reached 4600 mm 3 but was o150 mm 3 in the vector group at 32 days after implantation. Compared with the vector group, the expression of E-cadherin was decreased, whereas that of N-cadherin was increased in xenograft tumors in the SALL4 group (Figure 6e) , which is consistent with our in vitro results. We next wanted to know whether SALL4 overexpression also influenced the metastatic potential of gastric cancer cells in vivo. As shown in Figure 6f , all of the mice in the SALL4 group (6/6) exhibited ascites and disseminated tumors in the mesenterium and liver at 1 month after intraperitoneal injection. However, ascites was observed in only one mouse in the vector group (1/6), and no infiltration of tumor cells was observed. We determined the expression of SALL4 in mouse metastatic tumor tissues by using real-time RT-PCR and found that SALL4 level was higher than that in non-metastatic tumor tissues (Supplementary Figure S4) . Taken together, these results suggest that SALL4 overexpression enhances gastric cancer growth and metastasis in vivo. DISCUSSION SALL4 has a crucial role in maintaining embryonic stem cell pluripotency through the transcriptional modulation of Oct4 and Nanog.
9,11 SALL4 has been suggested as a 'core factor' for the SALL4/Nanog/Oct4 network. SALL4 can activate Oct4 and interact with Nanog. 5, 8, 11 In turn, Oct4 activates the transcription of SALL4, thus forming a positive SALL4/Oct4 transcriptional feedback loop. 11 We and others have previously demonstrated the overexpression of Oct4 and Nanog in human gastric cancer and suggested these pluripotency factors as independent biomarkers. [21] [22] [23] However, the expression pattern and functional role of SALL4 in human gastric cancer are not well understood.
In this study, we investigated the clinical relevance of SALL4 in gastric cancer and demonstrated that SALL4 level was positively associated with lymph node metastasis, indicating that high level of SALL4 predicts more metastatic gastric cancer. Metastasis is one of the malignant properties of cancer and the major cause of cancer death. EMT is an important process during normal development and in cancer cell metastasis. The occurrence of EMT during tumor progression allows benign tumor cells to acquire the capacity to permeate surrounding tissue and to eventually metastasize to distant sites. 24 We demonstrated that SALL4 overexpression enhanced gastric cancer cell migration, whereas knockdown of SALL4 (albeit using a single siRNA) showed the opposite effect. Furthermore, SALL4 overexpression reduced the expression of epithelial markers (E-cadherin) but increased the expression of mesenchymal markers (Twist1 and N-cadherin) in gastric cancer cells, suggesting that the induction of EMT may be, at least partially, responsible for the increased aggressiveness of SALL4-overexpressing gastric cancer cells. SALL4 regulates Bmi-1 transcription in both hematopoietic and leukemic cells. 13 Bmi-1 acts as an oncogene in gastric cancer development, progression and metastasis. 25 We found that SALL4 overexpression upregulated Bmi-1 in HGC27 gastric cancer cells. Therefore, it is possible that SALL4 also regulate gastric cancer progression and metastasis through the modulation of Bmi-1.
Cancer stem cells have been identified in hematopoietic and solid tumors, including acute myeloid leukemia, 26 breast cancer, 27 lung cancer, 28 ovary cancer, 29 prostate cancer 30 and liver cancer. 31 Cancer stem cells are able to initiate tumorigenesis and cause tumor metastasis. 32 These cells are believed to give rise to phenotypically diverse tumor cell populations. [33] [34] [35] EMT induced by Twist/Snail also generates cells with the properties of stem SALL4 as a marker for human gastric cancer L Zhang et al cells. 18 In the current study, we found that SALL4 overexpression endowed the gastric cancer cells with stem cell properties. The cells stably transfected with SALL4 showed increased expression of stem cell markers and displayed multipotent differentiation potential, supporting that SALL4 might be involved in the generation and maintenance of cancer stem cells in gastric cancer.
SALL4 regulates cell fate decision in fetal hepatic stem cells and has been suggested as a stem cell biomarker for liver cancer. 16 Normal stem cells and cancer stem cells share similar gene expression profiles and signaling pathways that are associated with self-renewal and differentiation. SALL4 is associated with three known pathways that are involved in self-renewal: Wnt/b-catenin, 12 Bmi-1, 13, 36 and PTEN. 37 SALL4 is able to bind b-catenin and activate the Wnt/b-catenin signaling pathway. 12 Bmi-1 and PTEN have been confirmed to be direct downstream targets of SALL4. 13, 37 The deregulation of SALL4-Wnt/Bmi-1/PTEN network has been linked to leukemogenesis. Although we demonstrated in this study that SALL4 regulated the metastatic potential and stemness of gastric cancer cells, the exact role of SALL4 in these processes still needs to be further investigated. The involvement of the aforementioned signaling pathways in gastric carcinogenesis and metastasis will be tested in the future work. In addition, the mechanisms responsible for the aberrant expression of SALL4 in gastric cancer are not very clear. Signal transducer and activator of transcription 3 (STAT3) has been demonstrated as a transcriptional regulator of SALL4. 38 Given that STAT3 drives the initiation and progression of gastric cancer, 39, 40 whether the increased expression of SALL4 in gastric cancer is caused by STAT3 hyperactivation will also be explored in future studies.
In conclusion, our findings suggest that SALL4 enhances the growth and metastasis of gastric cancer cells in vitro and in vivo. SALL4 functions as an oncogene through the regulation of EMT and cell stemness in gastric cancer. The identification of the role of SALL4 in gastric cancer provides a novel diagnostic biomarker and therapeutic target for gastric cancer.
MATERIALS AND METHODS

Human gastric cancer samples
The primary gastric cancer tissues and their matching, adjacent noncancerous tissues (located more than 5-10 cm away from the primary site) were collected from 72 gastric cancer patients undergoing surgery at the Generation of stable SALL4-overexpressing cell line Stable SALL4 overexpression in HGC-27 cells was achieved using SALL4 expression plasmid (RC213089) and pCMV6-Entry vector plasmid (PS100001) purchased from OriGene (OriGene, Rockville, MD, USA). HGC-27 gastric cancer cells were transfected with 4 mg of SALL4 plasmid, and the expression of SALL4 was confirmed by real-time RT-PCR and western blotting. At 48 h post transfection, the cells were selected with 600 mg/ml of G418, and the positive clones were picked up for further expansion.
Immunofluorescence
Cells cultured in 24-well chamber slides were washed twice with cold phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.1% Triton X-100 for 5 min, blocked with 5% BSA, incubated with indicated primary antibodies at 4 1C overnight and followed by a Cy3-conjugated anti-rabbit secondary antibody. The cells were then stained with DAPI (4,6-diamidino-2-phenylindole) for nuclear staining, and the images were acquired with a Nikon eclipse Ti-S microscope (Nikon, Tokyo, Japan).
Cell counting
Cells were seeded into 24-well plate (2 Â 10 4 cells/well) overnight. The cells were collected and counted at the indicated time points (24, 48, 72 and 96 h). Fold change of cell number was calculated.
Transwell migration assay Cells (1 Â 10 5 /well) were plated into the top chamber and 10% FBS containing medium was placed into the bottom chamber. After incubation at 37 1C in 5% CO 2 for 12 h, the cells remaining at the upper surface of the membrane were removed with a cotton swab. The cells that migrated through the 8-mm sized pores and adhered to the lower surface of the membrane were fixed with 4% paraformaldehyde, stained with crystal violet and photographed.
Colony-formation assay
Cells were harvested and seeded into six-well plate (500 cells/well) and incubated at 37 1C in a 5% CO 2 humidified incubator for 14 days. The medium was changed at 3-days interval. At the end of the incubation period, the cultures were fixed with 4% paraformaldehyde and stained with crystal violet.
Osteogenic and adipogenic differentiation in vitro HGC-27 cells stably expressing SALL4 or vector were seeded at 5000 cells/ cm 2 in 35-mm plates and cultured in DMEM with 10% FBS, 1% antibiotics and osteogenic supplement (0.1 mM dexamethasone, 10 mM b-glycerophosphate, 50 mg/l ascorbic acid) for 3 weeks with medium changed every
